SER
SER
AMEX · Biotechnology

Serina Therapeutics Inc.

Penny Stocks Biotech Stocks Healthcare Stocks
$2.80
-0.05 (-1.75%)
As of Aug 14, 10:17 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +872.1% upside
Low Target $16.99
Average Target $27.22
High Target $37.92
Current Price $2.80
Current
$2.80
Target
$27.22
$16.99 $27.22 avg $37.92
Scenario Analysis
Bear Case
$16.99
506.8%
Low target
Base Case
$27.22
+872.1%
Avg target
Bull Case
$37.92
+1,254.3%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.92
-64.6% from high
52-Week Low
$1.22
+129.5% from low
Target vs 52W High
$27.22
+243.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%